Chlorthalidone — known by the brand name Thalitone — is the American College of Cardiology and American Heart Association’s preferred first-line treatment for high blood pressure, but a recent study found that the drug may cause more serious side effects than similar drugs.
The February 2020 cohort study by Drs. George Hripcsak, Marc A. Suchard and Steven Shea published in JAMA Internal Medicine looked at medical data from 730,255 people. Researchers compared the safety and effectiveness of chlorthalidone and a similar drug, hydrochlorothiazide.
Chlorthalidone and hydrochlorothiazide are both diuretics — also called “water pills” — and belong to the thiazide-like and thiazide drug classes, respectively. They work to lower blood pressure by causing the kidneys to remove excess water and salt from the body through urine.
According to the JAMA study, both drugs are just as effective and chlorthalidone doesn’t protect the heart any better than hydrochlorothiazide. But chlorthalidone was associated with a “significantly higher risk” of side effects.
Chlorthalidone increased the risk of the following side effects when compared to hydrochlorothiazide:
“The difference in the occurrence of side effects was striking,” Dr. Hripcsak told Columbia University. “Hypokalemia, hyponatremia, chronic and acute kidney problems, along with other electrolyte imbalances, are all potentially dangerous side effects.”
Researchers say their findings don’t support chlorthalidone as the preferred treatment, but more studies are needed before regulators change guidelines.
Thiazide and thiazide-like drugs have been around since the late 1950s, and health care providers have prescribed them to lower blood pressure for decades. This makes them the oldest type of blood pressure drug on the market.
About 103 million Americans have high blood pressure, according to the American Heart Association. High blood pressure is a serious condition that can lead to heart attack, stroke, heart failure and other serious diseases.
Health care providers in the Unites States write about 49 million prescriptions a year for hydrochlorothiazide alone, according to Consumer Reports.
Thiazide and thiazide-like drugs are also less expensive than other blood pressure medications such as valsartan, losartan and lisinopril — many of these other blood pressure drugs were included in N-nitrosodimethylamine (NDMA) contamination recalls in 2018.
The 2020 JAMA study isn’t the first study to find side effects with chlorthalidone, according to Columbia University. Previous studies found that the drug was associated with more electrolyte imbalances than hydrochlorothiazide.
Electrolyte balance refers to the balance between sodium, calcium, potassium, chloride, phosphate and magnesium in the body. Too little or too much water in the body can cause these levels to become imbalanced and lead to several side effects.
According to the Thalitone drug label, all patients taking chlorthalidone should be observed for clinical signs of electrolyte imbalance, including:
The label also warns that people with liver problems who take chlorthalidone should use caution. Electrolyte imbalance is particularly dangerous for people with liver problems, because minor electrolyte imbalance can cause hepatic coma — a loss of brain function that happens when the liver doesn’t remove toxins from the blood.
Other side effects have been reported with chlorthalidone use, but there isn’t enough data for researchers to determine their frequency, according to the drug label.
Other side effects include:
People with moderate or severe side effects may need to adjust their dose or discontinue chlorthalidone, according to the drug label. Patients who experience side effects should speak to their health care providers.
Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.
Drugwatch's sponsors support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our sponsors page.(888) 645-1617